Detect Cancer Earlier


Optinosis detects cancer early, finding patients with undiagnosed cancer, helping payers and value-based care providers reduce late‑stage cancer costs.

Detecting cancers earlier means patients live longer, healthier lives and payers and value-based care providers realize dramatically lower treatment costs.

Supervised machine learning models analyze existing claims data to identify high risk patients.

Care Managers can guide high-risk individuals to earlier screening, diagnosis, and treatment.

Earlier detection leads to lower treatment costs and dramatically better patient outcomes.

We Passionately Pursue Early Diagnosis Because it Helps Patients, Payers, and Value-Based Care Providers

Identifying and treating cancers in earlier stages provides clinical and financial benefits to three key healthcare stakeholders.

Late Detection

Late detection is a big problem for patients and our country. Cancer is the leading cause of death across the globe.1

  • More than 2 million new cancer diagnoses occur annually in the U.S.2
  • The majority of cancers are still diagnosed at stage III or IV when treatments are costly and debilitating.3
  • Annual global cancer diagnoses are expected to rise to 29.9M by 2040.4
  • The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population.5

Early Detection

Together, we can lower healthcare costs and improve patient outcomes:

  • Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers.6
  • U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages.7
  • In the U.S. it is estimated that if all cases of melanoma, breast, lung and colorectal cancers were diagnosed at stages I or II, the national cost-savings would range from $1.56 to $3.47 billion dollars.8
Top 4 U.S. Most
Prevalent Cancers		 5-Year Patient Survival
with Early Detection
(stage I, II)*		 5-Year Patient Survival
with Late Detection
(stage III, IV)		 Year 1 Cost of Care Savings to
Payers and VBC Providers
(Stage I vs. Stage IV)**
Lung 67% 27% $90-100K
Colorectal 89.3% 16.4% $90-100K
Prostate 100% 37.9% $50-60K
Breast 91.6% 32.9% $50-70K

*American Cancer Society: Cancer Facts and Figures 2026
**Cost of cancer management by stage at diagnosis among Medicare beneficiaries.

“The greatest need we have today in the human cancer problem, except for a universal cure, is a method of detecting the presence of cancer before there are any clinical signs of symptoms.”
– Sidney Farber, letter to Etta Rosensohn, November 1962

Our Opportunity

Cancer is the leading cause of death across the globe. And, it’s growing:

2024 will be the first year that new cancer diagnoses exceed 2M in the U.S.1

Annual global cancer diagnoses are expected to rise to 29.9M by 2040.2

U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages.3

Our Mission

Together, We Can Lower Healthcare Costs and Improve Patient Outcomes.

Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers.4

Early diagnosis across 19 cancers could result in an estimated $26 billion cost-savings, representing about 17% of the direct costs related to cancer treatment.5

Schedule a Demo

Fill out the form below and we will be in touch.